Regen Biopharma's total assets for Q were $170.15K, an increase of 20.87% from the previous quarter. RGBP total liabilities were $5.33M for the fiscal quarter, a 0.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.